Gault Mandy L, Willems Mark E T
Institute of Applied Sciences, University of Chichester, Chichester PO19 6PE, UK.
Clin Pract. 2024 Feb 8;14(1):327-336. doi: 10.3390/clinpract14010025.
Exercise is a recommended part of phase IV cardiovascular rehabilitation (CR). The 1 km treadmill walk test (1-KTWT) is a submaximal continuous exercise test to predict cardiorespiratory fitness in patients with cardiovascular disease. We examined physiological, metabolic and subjective responses in patients with cardiovascular disease with self-selected, unchanging walking speed for two 1-KTWTs. Fifteen men (age: 65 ± 9 yr, height: 174 ± 5 cm, body mass: 86 ± 17 kg, BMI: 28.5 ± 5.5 kg·m, body fat%: 27.7 ± 7.5%, 10 on beta-blockers) were recruited from phase IV CR groups in the United Kingdom. Participants established a self-selected walking speed for the 1-KTWT and performed the 1-KTWT on separate days with recording of physiological responses to predict V˙O with equations. For the two 1-KTWTs, no differences existed for walking speed, mean and maximal heart rates, oxygen uptake, predicted V˙O (1st 1-KTWT (range: 41-78% V˙O, 95%CI, 53-65; 2nd 1-KTWT range: 43-78% V˙O, 95%CI, 52-65) and rating of perceived exertion. In phase IV cardiac patients, the 1-KTWT with self-selected, unchanging walking speed can be used for V˙O prediction without the need for a full familiarisation. The self-selected constant walking speed for the first 1-KTWT can be used to support nonsupervised physical activity for phase IV CR patients.
运动是心血管康复(CR)第四阶段的推荐内容。1公里跑步机步行测试(1-KTWT)是一种亚极量持续运动测试,用于预测心血管疾病患者的心肺适能。我们对心血管疾病患者在两次1-KTWT中以自我选择的恒定步行速度进行测试时的生理、代谢和主观反应进行了研究。从英国的心血管康复第四阶段组中招募了15名男性(年龄:65±9岁,身高:174±5厘米,体重:86±17千克,体重指数:28.5±5.5千克·米²,体脂率:27.7±7.5%,其中10人服用β受体阻滞剂)。参与者为1-KTWT确定了自我选择的步行速度,并在不同日期进行1-KTWT,同时记录生理反应,以便用公式预测摄氧量(V˙O₂)。在两次1-KTWT中,步行速度、平均心率和最大心率、摄氧量、预测的V˙O₂(第一次1-KTWT(范围:41-78%V˙O₂,95%置信区间,53-65;第二次1-KTWT范围:43-78%V˙O₂,95%置信区间,52-65)和主观用力程度评分均无差异。在心血管康复第四阶段的患者中,以自我选择的恒定步行速度进行的1-KTWT可用于预测V˙O₂,而无需进行充分的适应性训练。第一次1-KTWT的自我选择恒定步行速度可用于支持心血管康复第四阶段患者的非监督体力活动。